Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00713414 · ClinicalTrials.gov registry record

Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia

A clinical trial of Focal Dystonia and Spasmodic Dysphonia, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
37
Enrollment target
1
Study location

NCT00713414 is a study of Focal Dystonia and Spasmodic Dysphonia that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 37 participants, above the 28-participant average among 8 other Focal Dystonia trials with a reported enrollment target (32% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00713414, a study of Focal Dystonia and Spasmodic Dysphonia, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
37 participants
Enrollment target
1
Study location

Study Summary

This study will examine how the brain controls speech in patients with spasmodic dysphonia, a voice disorder that involves involuntary spasms of muscles in the larynx (voice box), causing breaks in speech. Although the causes of spasmodic dysphonia are unknown, recent studies found changes in brain function in patients with the disorder that may play a role in its development. People between 21 and 80 years of age with adductor spasmodic dysphonia may be eligible for this study. Candidates are screened with the following procedures: Medical history and physical examination. Nasolaryngoscopy to examine the larynx. For this test, the inside of the subject s nose is sprayed with a decongestant and a small, flexible tube called a nasolaryngoscope is passed through the nose to the back of the throat to allow examination of the larynx. The subject may be asked to talk, sing, whistle and say prolonged vowels during the procedure. The nasolaryngoscope is connected to a camera that records the movement of the vocal cords during these tasks. Voice and speech recording to measure the type and severity of voice disorder. Subjects are asked questions about their voice disorder and their voice is recorded while they repeat sentences and sounds. Participants undergo positron emission tomography (PET) and magnetic resonance imaging (MRI) of the brain, as follows: PET: A catheter is placed in a vein in the subject s arm to inject a radioactive substance called a tracer that is detected by the PET scanner and provides information on brain function. \[11C\]flumazenil is used in one scanning session and \[11C\]raclopride is used in another. For the scan, the subject lies on a bed that slides in and out of the doughnut-shaped scanner, wearing a custom-molded mask to support the head and prevent it from moving during the scan. For the first scan the subject lies quietly for 60 minutes. For the second scan, the subject lies quietly for 50 minutes and is then asked to say sentences d

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2008-07-09
Est. Completion 2016-09-21

What the Registry Record Tells You About NCT00713414

The ClinicalTrials.gov registry entry for NCT00713414 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 28-participant average among 8 other Focal Dystonia trials with a reported enrollment target (32% higher). The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Focal Dystonia appearing as the primary indexed condition, and to 0 interventions.

NCT00713414 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00713414 about?

NCT00713414 is a clinical study titled "Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia". This study will examine how the brain controls speech in patients with spasmodic dysphonia, a voice disorder that involves involuntary spasms of muscles in the larynx (voice box), causing breaks in speech. Although the causes of spasmodic dysphonia are unknown, recent studies found changes in brain ...

What is the current status of trial NCT00713414?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2008-07-09. Estimated completion is 2016-09-21.

What conditions does trial NCT00713414 study?

This clinical trial studies the following conditions: Focal Dystonia, Spasmodic Dysphonia.

Who is sponsoring clinical trial NCT00713414?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00713414 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Focal Dystonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.